Brief: LAVA Therapeutics Q3 basic EPS USD -0.34
Nov 16 (Reuters) - LAVA Therapeutics Q3 net income USD -8.836 million. * Q3 basic EPS USD -0.34 * Q3 pretax profit USD -8.786 million * Q3 gross profit USD 43 thousand * Q3 operating income USD -10.727 million * Q3 operating expenses USD -10.77 million
Recent news on LAVA Therapeutics NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:29 PM
Brief: Xoma Royalty Announces Closing Of Transactions To Acquire Lava Therapeutics N.V.
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM